Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2021 Sep 16;22(1):631.
doi: 10.1186/s13063-021-05602-0.

Employing a mobile health decision aid to improve decision-making for patients with advanced prostate cancer and their decision partners/proxies: the CHAMPION randomized controlled trial study design

Lourdes R Carhuapoma  1   2 , Winter M Thayer  3 , Catherine E Elmore  1 , Jane Gildersleeve  1 , Tanmay Singh  4 , Farah Shaukat  3 , Melissa K Uveges  5 , Tamryn Gray  6 , Crystal Chu  1 , Daniel Song  4 , Patricia J Hollen  1 , Jennifer Wenzel  3 , Randy A Jones  7
Affiliations
Randomized Controlled Trial

Employing a mobile health decision aid to improve decision-making for patients with advanced prostate cancer and their decision partners/proxies: the CHAMPION randomized controlled trial study design

Lourdes R Carhuapoma et al. Trials. .

Abstract

Background: Metastatic prostate cancer remains a lethal malignancy that warrants novel supportive interventions for patients and their decision partners and proxies. Decision aids have been applied primarily to patients with localized disease, with minimal inclusion of patients with advanced prostate cancer and their decision partners. The use of a community patient navigator (CPN) has been shown to have a positive supportive role in health care, particularly with individuals from minority populations. Research is needed to evaluate decision support interventions tailored to the needs of advanced prostate cancer patients and their decision partners in diverse populations.

Methods: Guided by Janis and Mann's Conflict Model of Decision Making, the Cancer Health Aid to Manage Preferences and Improve Outcomes through Navigation (CHAMPION) is a randomized controlled trial to assess the feasibility and acceptability of a mobile health (mHealth), CPN-administered decision support intervention designed to facilitate communication between patients, their decision partners, and the healthcare team. Adult prostate cancer patients and their decision partners at three mid-Atlantic hospitals in the USA were randomized to receive enhanced usual care or the decision intervention. The CHAMPION intervention includes a theory-based decision-making process tutorial, immediate and health-related quality of life graphical summaries over time (using mHealth), values clarification via a balance sheet procedure with the CPN support during difficult decisions, and facilitated discussions with providers to enhance informed, shared decision-making.

Discussion: The CHAMPION intervention is designed to leverage dynamic resources, such as CPN teams, mHealth technology, and theory-based information, to support decision-making for advanced prostate cancer patients and their decision partners. This intervention is intended to engage decision partners in addition to patients and represents a novel, sustainable, and scalable way to build on individual and community strengths. Patients from minority populations, in particular, may face unique challenges during clinical communication. CHAMPION emphasizes the inclusion of decision partners and CPNs as facilitators to help address these barriers to care. Thus, the CHAMPION intervention has the potential to positively impact patient and decision partner well-being by reducing decisional conflict and decision regret related to complex, treatment-based decisions, and to reduce cancer health disparities. Trial registration ClinicalTrials.gov NCT03327103 . Registered on 31 October 2017-retrospectively registered. World Health Organization Trial Registration Data Set included in Supplementary Materials.

Keywords: Advanced prostate cancer; Community patient navigator; Decision aid; Decision-making; Minorities; mHealth.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interests.

Figures

Fig. 1
Fig. 1
Trial design schematic for schedule of enrollment, interventions, and assessments
Fig. 2
Fig. 2
CHAMPION study design flow chart
See this image and copyright information in PMC

References

    1. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA: Ca-Cancer J Clin 2019;69(1):7–34. PMID: 30620402 doi:10.3322/caac.21551. - PubMed
    1. Howlader N, Noone A, Krapcho M, Miller D, Bishop K, Kosary C, et al., editors. SEER Cancer Statistics Review. Bethesda, Maryland: National Cancer Institute. 2017. http://seer.cancer.gov/csr/19752014/. Accessed 24 Jul 2019.
    1. Kelly SP, Anderson WF, Rosenberg PS, Cook MB. Past, current, and future incidence rates and burden of metastatic prostate cancer in the United States. Eur Urol Focus. 2018;4(1):121–127. doi: 10.1016/j.euf.2017.10.014. - DOI - PMC - PubMed
    1. Roviello G, Corona SP, Aieta M, Roudi R. Influence of age and the Gleason Score in the choice of novel hormonal therapies before and after chemotherapy. Cancer Biother Radio. 2019;34(3):141–146. doi: 10.1089/cbr.2018.2702. - DOI - PubMed
    1. Wenzel JA, Mbah O, Xu J, Moscou-Jackson G, Saleem H, Sakyi K, Ford JG. A model of cancer clinical trial decision-making informed by African-American cancer patients. J Racial Ethn Health Disparities. 2015;2(2):192–199. doi: 10.1007/s40615-014-0063-x. - DOI - PMC - PubMed

Publication types

Associated data